Eylea 40mg Injection

Eylea 40mg/ml Injection contains aflibercept as the active ingredient. It is indicated for treatment of eye conditions characterised by impaired vision due to abnormal blood vessel formation within the eye. These conditions include wet age-related macular degeneration and diabetic macular edema. Clinical studies have demonstrated that this medication effectively reduces the risk of vision loss and improves visual acuity in patients with these conditions. Most patients tolerate it well, and the injection procedure is relatively quick and minimally invasive. Eylea Injection should be avoided if you have severe hypersensitivity reactions to other anti-VEGF medications. Inform your physician if you have glaucoma, a history of floaters or flashes, or other concurrent illnesses before receiving Eylea eye injection. The medication will not be administered if you have an infection or inflammation around the eye. Inform your doctor if eye surgery has been performed recently or is planned before receiving this medication.

Eylea injection uses include: Neovascular (wet) age-related macular degeneration (wet AMD) Diabetic macular edema (DME) Myopic choroidal neovascularization (myopic CNV) Macular edema secondary to retinal vein occlusion

Eylea medication works by binding to and blocking the activity of vascular endothelial growth factor (VEGF). This protein can cause abnormal blood vessel growth and leakage in the eye, leading to vision loss. By inhibiting the activity of VEGF, this medication can help reduce abnormal blood vessel growth and leakage and improve vision in some people with these eye conditions.

A healthcare provider will follow the Eylea Injection procedure around the eye in a clinical setting. The eylea injection dose and frequency of infusions will vary depending on the patient's medical condition, age, weight, and other factors such as eylea for macular degeneration. A person should not take a double dose to make up the second dose.

Like all medications, eylea injections for macular degeneration can cause some side effects, although not every person who takes it will experience them. Serious: Blood clots or stroke Heart attack Severe bleeding or hemorrhage Gastrointestinal perforation (a hole in the stomach or intestine) Severe infections Hypertensive crisis (a sudden and severe increase in blood pressure) Common: Eye pain, irritation, or redness Blurred vision Increased tear production Sensitivity to light Headache High blood pressure Nasal congestion Nausea Vomiting Diarrhea Back pain Joint pain

If you are currently being treated with eylea injections for diabetic retinopathy, it is crucial to notify your healthcare provider immediately if you feel any side effects or have any concerns. For pregnant individuals planning to conceive or breastfeeding, it is essential to consult with your healthcare provider to discuss the potential risks and benefits associated with the treatment. Patients with diabetic retinopathy should be closely monitored during treatment because this medication can worsen the condition. If you experience symptoms such as eye pain, worsening redness of the eye, reduced or blurry vision, or increased sensitivity to light while undergoing treatment, inform your doctor promptly. Lifestyle changes, including quitting smoking, maintaining a healthy weight, and following a healthy diet, can improve overall health and reduce the risk of cancer-related complications. Emotional support from family, friends, or support groups can help cancer patients manage their treatment challenges.